The Distinct Prandial and Basal Pharmacodynamics of IDegAsp Observed in Younger Adults Are Preserved in Elderly Subjects with Type 1 Diabetes

被引：0
|
作者：
Martina Brunner
Thomas Pieber
Stefan Korsatko
Harald Kojzar
Anne Louise Svendsen
Hanne Haahr
机构：
[1] Medical University of Graz,Division of Endocrinology and Metabolism, Department of Internal Medicine
[2] Novo Nordisk A/S,Biostatistics
[3] Novo Nordisk A/S,Clinical Pharmacology
来源：
Drugs & Aging | 2015年 / 32卷
关键词：
Elderly Subject; Insulin Aspart; Pharmacodynamic Profile; Glucose Infusion Rate; Insulin Degludec;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：583 / 590
页数：7
相关论文
共 50 条
  • [41] Naturalistically observed interpersonal problems and diabetes management in older adolescents and young adults with type 1 diabetes
    Rodriguez-Stanley, Jacqueline
    Zilioli, Samuele
    Carcone, April Idalski
    Slatcher, Richard B.
    Ellis, Deborah A.
    [J]. PSYCHOLOGY & HEALTH, 2023, 38 (02) : 214 - 229
  • [42] Post-prandial glucose excursions following four methods of bolus insulin administration in subjects with Type 1 diabetes
    Chase, HP
    Saib, SZ
    MacKenzie, T
    Hansen, MM
    Garg, SK
    [J]. DIABETIC MEDICINE, 2002, 19 (04) : 317 - 321
  • [43] Effect of carbohydrate source on post-prandial blood glucose in subjects with type 1 diabetes treated with insulin lispro
    Mohammed, NH
    Wolever, TMS
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 65 (01) : 29 - 35
  • [44] Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus
    Pipi, Elena
    Marketou, Marietta
    Tsirogianni, Alexandra
    [J]. WORLD JOURNAL OF DIABETES, 2014, 5 (04) : 505 - 510
  • [45] Geographical variability of the incidence of Type 1 diabetes in subjects younger than 30 years in Catalonia, Spain
    Abellana, Rosa
    Ascaso, Carlos
    Carrasco, Josep L.
    Castell, Conxa
    Tresserras, Ricard
    [J]. MEDICINA CLINICA, 2009, 132 (12): : 454 - 458
  • [46] Treatment Intensification by Stepwise Addition of Prandial Insulin Aspart to Once-Daily Basal Insulin Detemir in Subjects with Type 2 Diabetes: The STEPwise™ Trial
    Meneghini, Luigi F.
    Hermansen, Kjeld
    Mersebach, Henriette
    Svendsen, Anne Louise
    Kumar, Sudhesh
    [J]. DIABETES, 2010, 59 : A199 - A199
  • [47] Efficacy and Safety of a New Basal Insulin with a Bolus Boost (IDegAsp) Used Once Daily in Combination with Insulin Aspart (IAsp) in People with Type 1 Diabetes
    Hirsch, Irl B.
    Franek, Edward
    Courreges, Jean-Pierre
    Mersebach, Henriette
    Dykiel, Patrik
    Bode, Bruce W.
    [J]. DIABETES, 2011, 60 : A292 - A292
  • [48] Distinct pharmacodynamics of insulin glargine and insulin detemir: Crossover comparison in Type 1 and Type 2 diabetic patients on basal-bolus regimen
    Kato, Tomoko
    Tokubuchi, Ichiro
    Muraishi, Kazuhisa
    Sato, Shuichi
    Kato, Tamotsu
    Hara, Kento
    Tanaka, Kayo
    Kaku, Hiroo
    Tajiri, Yuji
    Yamada, Kentaro
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : E64 - E66
  • [49] Liraglutide preserved insulin secretion in adults with newly diagnosed type 1 diabetes: the NewLira trial
    Dejgaard, T. F.
    Frandsen, C.
    Kielgast, U.
    Andersen, H. U.
    Thorsteinsson, B.
    Krarup, T.
    Holst, J. J.
    Madsbad, S.
    [J]. DIABETOLOGIA, 2019, 62 : S75 - S75
  • [50] Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial
    Dejgaard, Thomas F.
    Frandsen, Christian S.
    Kielgast, Urd
    Andersen, Henrik U.
    Thorsteinsson, Birger
    Krarup, Thure
    Holst, Jens J.
    Madsbad, Sten
    [J]. DIABETES, 2019, 68
12345